Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 20, 2023
The COVID-19 pandemic spurred an acceleration in the development of global health technologies. These technologies—many of which are only just coming to market—have the potential to reshape health systems, with significant positive impacts on global health security and pandemic preparedness.
Blog Post
November 13, 2023
The COVID-19 pandemic caused losses of lives and livelihoods on a scale that many of us had never seen in our lifetimes, shedding light on the ways that pandemics are a “neglected dimension” of global security. And yet, as we are already observing, proposals for increased, sustained support for surv...
WORKING PAPERS
November 13, 2023
Epidemics and pandemics pose a sporadic and sometimes severe threat to human health. How should policymakers prioritize preventing and preparing for such events, relative to other needs? Our simulations suggest that an event having the mortality level of COVID-19 should not be considered a “once in ...
Blog Post
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
REPORTS
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
Blog Post
August 07, 2023
In a new paper, we argue that the idea of “stewardship”—and the tension between some stewardship policies and patient access—extends well beyond antimicrobials, to all drug classes. We consider the many reasons why governments opt to impose controls on medicines, and how rationales for control relat...
BRIEFS
July 31, 2023
India is racing against the clock in its fight against antimicrobial resistance. A combination of complex regulatory and procurement systems, a lack of health insurance penetration, and little groundwork on state and national action plans has stymied progress. A multifold approach is needed to impro...
BRIEFS
June 20, 2023
The Pandemic Fund should strategically invest in pandemic preparedness, including for its first call for proposals for surveillance, laboratories, and human resources. This strategic approach should consider both ex ante and ex post considerations of investments for pandemic preparedness.